SAA1 and inflammatory bowel disease: Our model suggests that in cases of chronic intestinal inflammation (e.g. inflammatory bowel disease) when SAA is expressed at high levels in the intestine, there may be SAA-mediated impacts on host systemic innate immune function [16–18].